Unknown OBSERVATIONAL NCT02544178

Study of Neurological Complication After Radiotherapy for High Grade Glioblastoma (EPIBRAINRAD)

EPIBRAINRAD : Study of Neurological Complication After Radiotherapy for Glioblastoma High Grade

Sponsor: Centre National de la Recherche Scientifique, France

Updated 12 times since 2017 Last updated: Sep 21, 2016 Started: Apr 30, 2015 Primary completion: Apr 30, 2018 Completion: Apr 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Leukoencephalopathy, this trial is ongoing. The trial is conducted by Centre National de la Recherche Scientifique, France and has accumulated 12 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

12 versions recorded

Sep 2025 — Present [monthly]

Unknown
Sep 2024 — Sep 2025 [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Dec 2021 — Jul 2024 [monthly]

Unknown Status
Jan 2021 — Dec 2021 [monthly]

Unknown Status

▶ Show 7 earlier versions

Nov 2020 — Jan 2021 [monthly]

Unknown Status
May 2020 — Nov 2020 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jun 2018 — May 2020 [monthly]

Recruiting
May 2018 — Jun 2018 [monthly]

Recruiting
Apr 2018 — May 2018 [monthly]

Recruiting

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Recruiting NA
Jan 2017 — Aug 2017 [monthly]

Recruiting NA

First recorded

Apr 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre National de la Recherche Scientifique, France
Sophie JACOB

Data source: Institut de Radioprotection et de Surete Nucleaire

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France
• Strasbourg, France